Home
Query results
Results for
EPB41L3
Expand for information on EPB41L3
EPB41L3
Description
erythrocyte membrane protein band 4.1 like 3
Aliases
4.1B, DAL-1, DAL1
Gene Identifiers
mRNA Identifiers
RefSeq (mRNA)
NM_001281533.1; NM_001281534.2; NM_001281535.1; NM_001330557.1; NM_012307.4; XM_011525623.3; XM_011525626.3; XM_011525632.3; XM_011525634.3; XM_011525637.3; XM_017025618.2; XM_017025619.2; XM_017025620.2; XM_017025621.2; XM_017025622.2; XM_017025623.2; XM_017025624.2; XM_017025625.2; XM_017025626.2; XM_017025627.2; XM_017025628.2; XM_017025629.2; XM_017025630.2; XM_017025631.2; XM_017025632.2; XM_017025633.2; XM_017025634.2; XM_017025635.2; XM_017025636.2; XM_017025637.2; XM_017025638.2; XM_017025639.2; XM_017025640.2; XM_017025641.2; XM_017025642.2; XM_017025643.2; XM_017025644.2; XM_017025645.2; XM_017025646.2; XM_017025647.2; XM_017025648.2; XM_017025649.2; XM_017025650.2; XM_017025651.2; XM_017025652.2; XM_017025653.2; XM_017025654.2; XM_017025655.2; XM_017025656.2; XM_017025657.2; XM_017025658.2; XM_017025659.2; XM_017025660.2
Protein Identifiers
RefSeq (protein)
NP_001268462.1; NP_001268463.1; NP_001268464.1; NP_001317486.1; NP_036439.2; XP_011523925.1; XP_011523928.1; XP_011523934.1; XP_011523936.1; XP_011523939.1; XP_016881107.1; XP_016881108.1; XP_016881109.1; XP_016881110.1; XP_016881111.1; XP_016881112.1; XP_016881113.1; XP_016881114.1; XP_016881115.1; XP_016881116.1; XP_016881117.1; XP_016881118.1; XP_016881119.1; XP_016881120.1; XP_016881121.1; XP_016881122.1; XP_016881123.1; XP_016881124.1; XP_016881125.1; XP_016881126.1; XP_016881127.1; XP_016881128.1; XP_016881129.1; XP_016881130.1; XP_016881131.1; XP_016881132.1; XP_016881133.1; XP_016881134.1; XP_016881135.1; XP_016881136.1; XP_016881137.1; XP_016881138.1; XP_016881139.1; XP_016881140.1; XP_016881141.1; XP_016881142.1; XP_016881143.1; XP_016881144.1; XP_016881145.1; XP_016881146.1; XP_016881147.1; XP_016881148.1; XP_016881149.1
Uniprot ID
Ensembl protein ID
Protein Architecture
SMART
Disease Mapping
Druggability
- Candidate cancer driver, TIME driver
- Damaged in 142/7921 TCGA samples
- Damaged in 52/1291 cell lines
- Fewer loss of function mutations
- Equal damaging SNVs/indels
- Fewer structural variants